Oritavancin diphosphate

Research use only, not for human use.

Oritavancin diphosphate is a novel semisynthetic glycopeptide antibiotic which is being developed for the treatment of serious Gram-positive bacterial infections.

Oritavancin diphosphate is a novel semisynthetic glycopeptide antibiotic which is being developed for the treatment of serious Gram-positive bacterial infections.

——

——

LY333328 diphosphate

Autophagy

Sigma receptor

Others

Infection

——

192564-14-0

1989.09

C86H103Cl3N10O34P2

>98% (HPLC)

DMSO : 14 mg/mL. 7.04 mM;

O[C@@H]1[C@@H](O[C@@H]2O[C@@H](C)[C@H](O)[C@@](C2)(C)NCc2ccc(c3ccc(Cl)cc3)cc2)[C@@H](O[C@H](CO)[C@H]1O)Oc1c2Oc3ccc([C@H]([C@@H](NC(=O)[C@H](NC)CC(C)C)C(=O)N[C@H](C(=O)N[C@@H]4c(c2)cc1Oc1ccc([C@H]([C@H]2C(=O)N[C@H](C(=O)O)c5c(c6cc([C@@H](NC4=O)C(=O)N2)ccc6O)c(O)cc(O)c5)O[C@@H]2O[C@@H](C)[C@H](O)[C@](C2)(N)C)cc1Cl)CC(=O)N)O)cc3Cl.O=P(O)(O)O.O=P(O)(O)O

——

(-20℃)

With Ice Pack

≥ 2 years